Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-01-30
2007-01-30
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S141100, C424S143100, C424S144100, C424S153100, C424S173100, C530S387100, C530S387300, C530S388100, C530S388200, C530S388220, C530S388700, C530S388730, C530S388750, C536S023100, C536S023500, C536S023530
Reexamination Certificate
active
10221529
ABSTRACT:
A CD154 binding molecule, in particular an antibody to human CD154, especially a human antibody to human CD154 is provided, wherein the CDRs of the heavy chain and light chain have amino acid sequences as defined, for use in the treatment and/or prevention of diseases or disorders wherein CD154 modulation and/or interference with or inhibition of the CD154:CD40 interactions is therapeutically beneficial.
REFERENCES:
patent: 6051228 (2000-04-01), Aruffo et al.
patent: 96/23071 (1996-08-01), None
patent: 96/33735 (1996-10-01), None
patent: 96/34096 (1996-10-01), None
patent: 99/12566 (1999-03-01), None
Schuler et al. Transplantation 77 : 717-726, 2004.
Rudikoff et al., Proc Natl Acad Sci USA 79: 1979-1983, 1982.
Colman, Research in Immunology 145: 33-36, 1994.
Kirk et al., “Treatment with Humanized Monoclonal Antibody Against CD154 Prevents Acute Renal Allograft Rejection in Nonhuman Primates”, Nature Medicine, vol. 5, No. 6, pp. 686-693 (1999).
Chambers-Slater et al., “A Humanized Anti-Human CD154 Monoclonal Antibody Blocks CD154-CD40 Mediated Human B Cell Activation”, The FASEB Journal, vol. 13, No. 5, Part 2, p. A988 (1999).
Di Padova Franco E
Schuler Walter
Gambel Phillip
Novartis AG
Savitsky Thomas R.
LandOfFree
Human CD154 binding molecules and treatment methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human CD154 binding molecules and treatment methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human CD154 binding molecules and treatment methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3725779